At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.
Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.
Chronic low back pain significantly affects quality of life for millions of people worldwide. Back pain makes it difficult to ...
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
A streamlined, nurse-led response for hospitalized patients experiencing an acute stroke at a Texas academic medical center ...
Experts discuss key challenges in hypothyroidism management, including diagnostic thresholds and appropriate use of ...
Discover how wearable technology, AI diagnostics, and remote monitoring are reshaping heart health for individuals over 40 in ...
Dr Emma Svennberg, cardiologist in Stockholm and first author of the consensus paper, noted that modern AF care requires a more streamlined and holistic approach. She highlighted the need to address ...
Svennberg E et al. Transforming Atrial Fibrillation Management by Targeting Comorbidities and Reducing Atrial Fibrillation Burden: the 10th AFNET/EHRA Consensus Conference. Europace, 15 Dec 2025. DOI: ...
Sportschosun on MSN
Fatty liver patients with metabolic abnormalities, high cirrhosis, are at risk of complications up t...
In patients with metabolic abnormal fatty liver disease (MASLD), if the blood test index is low but the cirrhosis is high, ...
People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback